Literature DB >> 19931401

(11)C-methionine uptake correlates with tumor cell density rather than with microvessel density in glioma: A stereotactic image-histology comparison.

Yoshiko Okita1, Manabu Kinoshita, Tetsu Goto, Naoki Kagawa, Haruhiko Kishima, Eku Shimosegawa, Jun Hatazawa, Naoya Hashimoto, Toshiki Yoshimine.   

Abstract

(11)C-methionine positron emission tomography ((11)C-methionine PET) provides accurate detection of brain tumors. Several reports have analyzed the correlation between uptake of (11)C-methionine and Ki-67 index or microvessel density non-stereotactically and suggested that (11)C-methionine uptake reflects both proliferation potential and angiogenic capability in gliomas. As gliomas possess heterogeneous histological architecture, non-stereotactic comparison of the histology and (11)C-methionine PET image may not be accurate. In the present study, the correlation between (11)C-methionine uptake and cell or microvessel density was analyzed using histological specimens obtained by stereotactic biopsy, and an exact local comparison of (11)C-methionine PET image and histological specimens was conducted. The tumor/normal tissue (T/N) ratio of (11)C-methionine positron emission tomography was found to correlate better with cell density (R=0.747, p=0.000042) and Ki-67 index (R=0.675, p=0.00041) than with microvessel density (R=0.467, p=0.025) in a histological comparison using a stereotactic image. Furthermore, multiple linear regression analysis revealed that cell density was the key determinant for predicting (11)C-methionine level while microvessel density was not. These results suggest that cell density contributes more to (11)C-methionine uptake than microvessel density in glioma tissues and that the previously reported correlation of (11)C-methionine uptake and microvessel density in glioma patients requires reevaluation. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19931401     DOI: 10.1016/j.neuroimage.2009.11.024

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  22 in total

1.  Advantage of 11C-methionine positron emission tomography for assessing IgG4-related central nervous system lesions.

Authors:  Kodai Kume; Kazuyo Ikeda; Kazushi Deguchi; Masaki Kamada; Masaki Okada; Takashi Tamiya; Tetsuo Touge; Tsutomu Masaki
Journal:  J Neurol       Date:  2014-02-16       Impact factor: 4.849

Review 2.  Discrimination between primary low-grade and high-grade glioma with 11C-methionine PET: a bivariate diagnostic test accuracy meta-analysis.

Authors:  Anna Falk Delgado; Alberto Falk Delgado
Journal:  Br J Radiol       Date:  2018-01-22       Impact factor: 3.039

3.  Detection of histological anaplasia in gliomas with oligodendroglial components using positron emission tomography with (18)F-FDG and (11)C-methionine: report of two cases.

Authors:  Shigeru Yamaguchi; Hiroyuki Kobayashi; Kenji Hirata; Tohru Shiga; Shinya Tanaka; Junichi Murata; Shunsuke Terasaka
Journal:  J Neurooncol       Date:  2010-06-15       Impact factor: 4.130

4.  Clinical characteristics of meningiomas assessed by ¹¹C-methionine and ¹⁸F-fluorodeoxyglucose positron-emission tomography.

Authors:  Hideyuki Arita; Manabu Kinoshita; Yoshiko Okita; Ryuichi Hirayama; Tadashi Watabe; Kayako Ishohashi; Noriyuki Kijima; Naoki Kagawa; Yasunori Fujimoto; Haruhiko Kishima; Eku Shimosegawa; Jun Hatazawa; Naoya Hashimoto; Toshiki Yoshimine
Journal:  J Neurooncol       Date:  2011-11-17       Impact factor: 4.130

5.  Hot spots in dynamic (18)FET-PET delineate malignant tumor parts within suspected WHO grade II gliomas.

Authors:  M Kunz; N Thon; S Eigenbrod; C Hartmann; R Egensperger; J Herms; J Geisler; C la Fougere; J Lutz; J Linn; S Kreth; A von Deimling; J C Tonn; H A Kretzschmar; G Pöpperl; F W Kreth
Journal:  Neuro Oncol       Date:  2011-02-03       Impact factor: 12.300

6.  Imaging ¹⁸F-fluorodeoxy glucose/¹¹C-methionine uptake decoupling for identification of tumor cell infiltration in peritumoral brain edema.

Authors:  Manabu Kinoshita; Tetsu Goto; Hideyuki Arita; Yoshiko Okita; Kayako Isohashi; Naoki Kagawa; Yasunori Fujimoto; Haruhiko Kishima; Eku Shimosegawa; Youichi Saitoh; Jun Hatazawa; Naoya Hashimoto; Toshiki Yoshimine
Journal:  J Neurooncol       Date:  2011-08-17       Impact factor: 4.130

7.  Usefulness of ¹¹C-methionine positron emission tomography for treatment-decision making in cases of non-enhancing glioma-like brain lesions.

Authors:  Atsushi Watanabe; Yoshihiro Muragaki; Takashi Maruyama; Jun Shinoda; Yoshikazu Okada
Journal:  J Neurooncol       Date:  2015-11-26       Impact factor: 4.130

8.  Quantitative PET imaging of tryptophan accumulation in gliomas and remote cortex: correlation with tumor proliferative activity.

Authors:  Csaba Juhász; Diane C Chugani; Geoffrey R Barger; William J Kupsky; Pulak K Chakraborty; Otto Muzik; Sandeep Mittal
Journal:  Clin Nucl Med       Date:  2012-09       Impact factor: 7.794

9.  Stereotactic image-based histological analysis reveals a correlation between 11C-methionine uptake and MGMT promoter methylation in non-enhancing gliomas.

Authors:  Yoshiko Okita; Tomoko Shofuda; Daisuke Kanematsu; Ema Yoshioka; Yoshinori Kodama; Masayuki Mano; Manabu Kinoshita; Masahiro Nonaka; Shin Nakajima; Toshiyuki Fujinaka; Yonehiro Kanemura
Journal:  Oncol Lett       Date:  2018-05-31       Impact factor: 2.967

10.  Correlation between positron emission tomography findings and glucose transporter 1, 3 and L-type amino acid transporter 1 mRNA expression in primary central nervous system lymphomas.

Authors:  Yoshinobu Takahashi; Toshiaki Akahane; Daisuke Yamamoto; Hideo Nakamura; Hiroki Sawa; Kazumi Nitta; Wataru Ide; Ikuo Hashimoto; Hajime Kamada
Journal:  Mol Clin Oncol       Date:  2014-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.